Glaucoma & Retina Treatment Cost in China 2026: prices by procedure
For international patients paying privately, glaucoma and retina care in China costs a fraction of Western private rates: SLT laser $400–700 for both eyes, MIGS $2,000–4,000 per eye, trabeculectomy $1,200–2,500 per eye, anti-VEGF injections $300–800 each, and vitrectomy $2,500–4,500 per eye (standard ranges, researched July 2026) — typically 60–80% below US private-pay pricing. This is the national price picture by procedure, with the candidacy caveats and the one thing that matters more than price for these conditions: how ongoing care gets handed back to your home specialist.
Glaucoma: SLT $400–700 both eyes · MIGS $2,000–4,000/eye · trabeculectomy $1,200–2,500/eye. Retina: anti-VEGF $300–800/injection · vitrectomy $2,500–4,500/eye. Which procedure — if any — fits your eyes is the treating specialist's decision after imaging, and both conditions need a written follow-up handover to your home ophthalmologist.
Price table by procedure (researched July 2026)
| Procedure | China (standard range) | US private-pay | Typical saving |
|---|---|---|---|
| SLT laser trabeculoplasty (both eyes) | $400–700 | $1,500–2,500 | ~72% |
| MIGS — micro-invasive stent (per eye) | $2,000–4,000 | $4,000–8,000 | ~50% |
| Trabeculectomy (per eye) | $1,200–2,500 | $6,000–11,000 | ~78% |
| Anti-VEGF injection (each, incl. imaging review) | $300–800 | $1,800–2,400 | ~74% |
| Vitrectomy (per eye) | $2,500–4,500 | $10,000–15,000 | ~72% |
Ranges are standard partner-hospital fee schedules researched July 2026, set against published US private-pay references. Glaucoma surgery and complex retina cases are ultimately quoted per case after imaging — combined procedures, re-operations and advanced disease price toward or above the top of each band. For every other eye procedure, see the full China eye surgery price guide.
Glaucoma: what each option is, and who it's for
Glaucoma treatment is a ladder, not a menu. Where you enter it depends on your pressure, your optic-nerve damage on OCT, your visual fields and what drops you're already on — all of which is why the procedure choice belongs to the treating specialist, not a price list:
- SLT laser (selective laser trabeculoplasty) — a 10-minute outpatient laser that improves natural drainage. Often the first surgical step when drops aren't enough (or aren't tolerated), and repeatable. At $400–700 for both eyes it is the cheapest intervention on this page and the one most compatible with a short trip.
- MIGS (micro-invasive glaucoma surgery) — tiny stents or shunts implanted to lower pressure with faster recovery than traditional surgery, frequently combined with cataract surgery in one session. The imported device drives the $2,000–4,000 per-eye price; suitable mainly for mild-to-moderate open-angle glaucoma.
- Trabeculectomy — the traditional filtering surgery for advanced or fast-progressing disease. The most effective pressure-lowering operation and, in China, a high-volume routine procedure at academic centers ($1,200–2,500 per eye) — but it needs more follow-up visits than the other options, which matters when you live twelve time zones away. Discuss the post-operative review schedule before booking travel.
Angle-closure glaucoma — the subtype China has most of, and it prices differently
Everything above assumes open-angle glaucoma, which is what most Western patient guidance is written about. Angle-closure is a different disease with a different ladder — and it is the form the destination on this page sees most. An estimated 28.2 million angle-closure suspects and 9.1 million people with primary angle closure live in China, and of the more than 32 million people projected to have primary angle-closure glaucoma worldwide by 2040, roughly three quarters are in Asia. If you have been told your angles are narrow, this is the one part of eye care where China's academic centers hold the deepest case volume anywhere.
The practical consequence is that the operation you end up pricing may not be a glaucoma operation at all. The EAGLE trial (Lancet, 2016) compared early clear-lens extraction against laser peripheral iridotomy as first-line treatment for primary angle closure and primary angle-closure glaucoma: fewer patients needed further pressure-lowering treatment or surgery after lens extraction, and it was the more cost-effective option at three years despite costing more up front — though visual-field outcomes did not differ between the groups. Where a surgeon takes that route, the procedure being quoted is a cataract-style lens extraction, and its price sits on our cataract surgery cost guide, not in the table above. Establish which of the two you are being quoted for before you compare any numbers.
The largest trial on this question ran in the destination city. The Zhongshan Angle-Closure Prevention (ZAP) study — Zhongshan Ophthalmic Center with Moorfields/UCL and the Wilmer Eye Institute — randomised 889 Guangzhou residents who had narrow angles in both eyes to laser iridotomy in one eye only. At 14 years, iridotomy cut the risk of an eye progressing to angle closure by about two thirds — but the number of events was low in both groups, and the investigators concluded that population-wide preventive iridotomy is not warranted. Being labelled an angle-closure suspect is a reason to have gonioscopy and a conversation with an ophthalmologist you can reach, not a reason to book a flight. Whether your eyes need treating now is a decision made at the slit lamp by the treating specialist.
When trabeculectomy isn't the answer: drainage implants and cyclodiode
The three rungs listed above cover most first-time glaucoma surgery. They do not cover the cases that most often send someone looking abroad in the first place: a trabeculectomy that has already failed, neovascular glaucoma after diabetes or a retinal vein occlusion — the same patients the retina half of this page is written for — uveitic glaucoma, and eyes already scarred by earlier surgery or vitrectomy. In those eyes a conventional filtering operation has a poor chance of staying open, and the surgeon reaches for one of two things:
- A glaucoma drainage implant (tube shunt) — Ahmed, Baerveldt and PAUL are the device names you will see on a quote — a silicone tube that drains fluid to a plate stitched to the wall of the eye. The device tier accounts for most of the difference between one quote and another.
- Cyclophotocoagulation (transscleral diode, or micropulse) — a laser applied through the sclera that reduces how much fluid the eye produces, rather than improving drainage. It is short, repeatable and needs the lightest follow-up of anything on this page, which is why it is sometimes the realistic option in refractory disease or an eye with limited visual potential. It is not a substitute for filtering surgery in an eye with good vision.
Neither is a standard-range procedure, and neither belongs in the fee-schedule table above: both are quoted per case after imaging, because the device and the state of the eye set the price rather than a published rate. As a planning reference only, alongside the iridotomy named in the previous section:
| Procedure | China (domestic published reference) | US private-pay reference |
|---|---|---|
| Glaucoma drainage implant / tube shunt (per eye) | ≈$3,900–5,300 (¥28,000–38,000 all-in) | $4,000–8,000 |
| Laser peripheral iridotomy (per eye) | Quoted per case — outpatient laser | $1,000–2,000 |
Read this table differently from the one above. Its China column is domestic published pricing, researched August 2026 and converted at August 2026 rates — not a partner-hospital fee schedule — so the international-patient figure you are actually quoted may differ. The US column is published private-pay averages; tube shunts and trabeculectomy price similarly in the US, and self-pay quotes generally run above insurer-allowed rates. Two things follow, and both cut against travelling. The saving on this rung is the smallest anywhere on this page — an imported valve costs roughly what an imported valve costs, wherever it is implanted. And a re-operated or refractory eye carries the densest review schedule of any procedure here, which is precisely the thing that distance makes hard. We would rather set that out than leave it implied by a table.
A laser or surgery lowers pressure; it doesn't end the disease. Before you travel, confirm two things in writing: that you'll receive your full record set (pressure history, visual fields, OCT nerve scans, operative note in English), and that a named ophthalmologist at home will continue your pressure checks. If you can't arrange the second part, fix that before spending money on the first.
Retina: injections, vitrectomy — and when NOT to book a flight
Anti-VEGF injection courses treat wet macular degeneration, diabetic macular edema and retinal vein occlusion. The drug drives the price: domestic agents such as conbercept anchor the lower end of the $300–800 per-injection range, imported ranibizumab (Lucentis) and aflibercept (Eylea) the upper end. Two honest caveats. First, these conditions need injections on a recurring schedule — commonly monthly to start — so a single trip buys you a course review and one or two injections, not a cure; the realistic plan is starting or reassessing treatment in China and continuing it at home. Second, whether the domestic-drug price advantage survives your return depends on what your home country stocks — ask your home retina specialist before you build a plan around a drug they can't continue. If the underlying cause is diabetes, the staging matters more than the price list — our diabetic retinopathy guide prices each stage separately (screening, PRP laser, injection courses, diabetic vitrectomy) and is direct about which stages justify a trip and which don't.
The injection price is a drug price — which means it can run the other way
Worth understanding before you plan around that $300–800 figure. Vitrectomy is cheaper in China for the ordinary reason — theatre time, equipment and surgical hours cost less. An anti-VEGF injection is different: it is almost entirely a vial, wrapped in a five-minute procedure that is much the same everywhere. So the gap is a drug-price gap, and drug prices are not uniformly in China's favour.
The case that matters most for this page's readers is wet macular degeneration and retinal vein occlusion, where off-label repackaged bevacizumab is a mainstay in the United States and in several national systems precisely because it is cheap — published comparisons put it near $70 a dose against roughly $1,700–1,900 for licensed ranibizumab and aflibercept. Under US Medicare Part B in 2026, after the $283 deductible and 20% coinsurance, the drug component is a few dollars. Nothing on our price list competes with that, and we will not pretend otherwise: if bevacizumab is your specialist's default agent, flying for injections adds cost. The travel argument on this page rests on vitrectomy, MIGS and incisional glaucoma surgery, where operating time dominates the bill — not on injections. Where the domestic drug tier genuinely does change the arithmetic is for self-funded patients facing licensed-agent pricing at home, and that case is worked through in full — named agents, dosing intervals and a first-year rather than per-injection calculation — on our diabetic retinopathy drug-pricing section. If your injections are for diabetic macular edema specifically, read the prior question first — whether an eye with good reading vision needs injecting at all is a separate argument with trial evidence behind it, set out in our diabetic macular edema section.
Vitrectomy — the surgical removal of the vitreous gel to repair retinal detachment, advanced diabetic retinopathy, macular holes and epiretinal membranes — runs $2,500–4,500 per eye at China's high-volume vitreoretinal units, against $10,000–15,000 US private-pay. Complex cases (silicone-oil tamponade, combined cataract-vitrectomy, re-detachment) are quoted per case. Note that some vitrectomy patients receive a gas bubble, and flying is prohibited until the gas fully absorbs — which can mean two to eight extra weeks in-country or a surgeon-approved alternative plan. Ask about tamponade choice before you book a return flight; our flying after eye surgery guide explains why the gas rule is absolute and what the alternatives look like.
Sudden flashes, a shower of new floaters, or a dark curtain across your vision can mean retinal detachment — that needs assessment within days, wherever you are. Medical travel is for scheduled care: planned vitrectomy for stable conditions, injection-course reviews, diabetic retinopathy management. Never delay emergency treatment to save money abroad. If you are already in China when it happens, our retinal detachment emergency guide covers the 24-hour ophthalmic emergency route, the timing windows and how payment works.
Glaucoma and retinal disease are treated as medical care rather than elective surgery almost everywhere, which makes coverage the first thing to establish and the price table the second. In the United States, Medicare covers medically necessary glaucoma treatment once the diagnosis is made — including SLT, FDA-approved MIGS procedures and incisional surgery such as trabeculectomy — with 2026 cost-sharing of the $283 Part B deductible and 20% coinsurance. Most commercial plans and national systems take a similar line for medically-indicated eye care. If you are covered on that basis, travelling for glaucoma or retinal treatment usually makes no financial sense, and the clinical argument runs the same way: this page already says chronic pressure control and injection courses belong with a doctor you can reach.
The trip earns its place in narrower cases: you are uninsured or facing a large deductible; you are an expatriate without local cover; the procedure is not funded or carries a long wait where you live; or a scheduled operation can be combined with other work in one visit. Confirm your own position with your plan administrator or insurer before committing — this is a general summary researched July 2026, coverage rules change and vary by plan, and nothing here is insurance advice.
Where this care is done
Glaucoma and vitreoretinal disease are subspecialties, and the right destination is a center with a dedicated department, not a general clinic that also does laser vision correction. China's academic eye centers — Zhongshan Ophthalmic Center (Guangzhou), Beijing Tongren, the Eye & ENT Hospital of Fudan University (Shanghai), Tianjin Eye Hospital and Wenzhou Medical University Eye Hospital — all run high-volume glaucoma and retina units, and private networks such as Aier and He Eye Specialist Hospital offer international-patient services around the same subspecialties. Our guide to China's best eye hospitals explains how to match institution to condition, and the for-foreigners guide covers how the international departments, English records and payment actually work.
How long you'd stay
| Treatment | Typical stay |
|---|---|
| SLT laser (both eyes) | 2–4 days |
| Anti-VEGF injection + imaging review | 2–3 days per visit |
| MIGS (often combined with cataract) | 5–8 days |
| Trabeculectomy | 7–14 days — surgeon-directed review schedule |
| Vitrectomy | Per case; gas tamponade can bar flying for 2–8 weeks |
Every one of these is surgeon-directed: flight clearance is a clinical decision made at your final review, not a booking default. Build refundable flexibility into return travel for anything beyond SLT.
The trip, stage by stage — and where it can still be called off
Every stage below exists to stop a trip that should not happen. The two decision points that matter are before you buy a ticket and on the day you are examined in person; nothing on this page commits a surgeon to operating, and the operating surgeon can and does change the plan after imaging.
| Stage | When | What has to be true to go on |
|---|---|---|
| 1. Records | Week 0 | Pressure history, visual fields, OCT nerve and macular scans, current drops and doses, any previous operative notes. For retina: a recent OCT, not one from last year. |
| 2. Remote subspecialty review | Week 0–2 | A glaucoma or vitreoretinal specialist — not a coordinator — has read the file and named a likely procedure and a price band. If the answer is "keep treating this at home", the trip ends here, and on this page that is the common answer. |
| 3. Home follow-up secured | Before booking | A named ophthalmologist at home has agreed to do your post-operative reviews. See the failure modes below for why this stage, not the surgery, is the one that decides whether the trip was worth taking. |
| 4. In-person work-up | Day 1–2 | Gonioscopy, repeat imaging, pressures. The procedure named at stage 2 is confirmed, changed or withdrawn. Price is re-quoted here, and this is the figure that counts. |
| 5. Procedure | Day 2–4 | Surgeon-directed. Combined operations (MIGS with cataract, phaco with vitrectomy) are decided at this point, not booked in advance. |
| 6. Reviews in-country | Day 3 to week 2 | The densest part of the schedule. Trabeculectomy in particular is reviewed repeatedly in the first fortnight; leaving early is the single most common way to lose the benefit of the operation. |
| 7. Flight clearance and handover | Final review | A clinical decision, never a booking default — and it is refused outright while an intraocular gas bubble remains. You leave with the English record set listed below. |
| 8. Home monitoring | Lifelong | Glaucoma is a lifelong pressure problem and a bleb is a lifelong feature of the eye. Stage 3 is what makes this stage possible. |
What can go wrong — and what each one costs you in trips
Complication rates in China's high-volume units are broadly comparable to those reported in Western series for the same operations, and our safety guide sets out that comparison. That is not the useful question for a traveller. The useful question is what each recognised complication does to an itinerary and a budget, because a complication that is a routine second visit at home becomes a second international trip from abroad. Each figure below is included only because it changes something you would do.
| What can happen | How often, roughly | What it costs a traveller — and the action |
|---|---|---|
| Cataract after vitrectomy (if you still have your own lens and are over 50) | Near-universal lens change within about two years; roughly 60% have cataract surgery in that window, and nuclear-sclerosis progression is around sixfold faster over 50 than in younger eyes | A second operation, and usually a second trip. This is the most predictable item on the page. Action: ask explicitly whether combined phaco-vitrectomy is appropriate for your eye — doing both in one visit is often the difference between one itinerary and two, and it changes the quote at stage 4. |
| Retinal detachment does not stay attached after the first operation | Modern single-operation success is roughly 90–95%, so a minority need a second procedure | The quoted price is a single-operation price. Action: before you travel, ask what a re-operation is priced at and who pays for it — a partner hospital should answer in writing. |
| Trabeculectomy bleb scars down or drains too much (needling, revision, hypotony) | Revision in the early weeks is common enough to plan for, not rare | Falls in exactly the window when you would be flying home. Action: treat stage 3 as mandatory for trabeculectomy, and build refundable flexibility into the return flight rather than a fixed date. |
| Bleb-related infection after trabeculectomy | Uncommon, but the risk does not expire — it persists for the life of the bleb | An emergency wherever you are, years later. Action: make sure your home doctor's record states that you have a functioning bleb and which eye, and that you know to present the same day for a red, painful or suddenly blurred eye. |
| Gas tamponade after vitrectomy | A planned part of many retina operations, not a complication | Flying is barred until the bubble absorbs — two to eight weeks. Action: ask about tamponade choice before booking a return flight; see our flying guide. |
| Endophthalmitis after an anti-VEGF injection | Rare — well under one in a thousand injections | Its significance here is the schedule, not the odds. Action: an injection course needs someone reachable within 24 hours for years, which is the argument this page already makes for keeping injection care at home. |
None of the above is a reason on its own not to travel, and none of it is a prediction about your eyes. The pattern is the point: on this page the expensive risk is almost never the operation — it is the follow-up you cannot reach. That is why stage 3 sits before booking rather than after, and why we would rather lose the case than route a trabeculectomy or a re-detachment to a patient with no ophthalmologist at home. Which complications apply to you is a matter for the treating specialist after imaging, and figures here are drawn from the published surgical literature rather than from any single hospital's results. This section sits outside the cataract subspecialty of this page's named medical reviewer and is queued for review by a glaucoma and vitreoretinal specialist; it is reported as published findings, not as a prediction for any reader's eye.
The records your home doctor needs
For chronic eye disease, the trip is only as good as the handover. A usable record set from a Chinese international patient department includes: the operative or procedure note in English, your pressure (IOP) history during the visit, baseline and post-treatment visual fields, OCT nerve and macular scans in a shareable digital format, the exact drug and dose of any injection given, and a written follow-up schedule. Ask for this list by name before you pay — reputable centers provide it as routine, and its absence is a red flag (our safety guide covers the other ones).
Frequently asked questions
How much does glaucoma treatment cost in China?
For international patients paying privately (standard partner-hospital ranges, researched July 2026): SLT laser trabeculoplasty runs $400–700 for both eyes, micro-invasive glaucoma surgery (MIGS) $2,000–4,000 per eye depending on the stent device, and trabeculectomy $1,200–2,500 per eye. That is typically 60–80% below US private-pay rates. Which procedure fits your glaucoma — if any — is decided by the treating specialist after pressure, visual-field and OCT nerve imaging.
How much do anti-VEGF injections cost in China?
Anti-VEGF retinal injections in China cost roughly $300–800 per injection including the imaging review (researched July 2026). The drug drives the range: domestic agents such as conbercept sit at the lower end, imported ranibizumab and aflibercept at the upper end. US private-pay pricing for the same imported drugs commonly runs $1,800–2,400 per injection. Two caveats matter. Macular conditions need injections on an ongoing schedule, so a China trip suits the start or review of a course rather than a one-time cure. And because an injection is almost entirely a vial rather than theatre time, this is a drug-price comparison, which does not always favour China.
Should I fly to China just for anti-VEGF injections?
Usually not, and we would rather say so. If your retina specialist treats you with off-label repackaged bevacizumab — a mainstay in the United States and in several national health systems at around 70 US dollars a dose, against roughly 1,700 to 1,900 dollars for the licensed agents — then no Chinese price competes with it. Under US Medicare Part B in 2026 your share after the 283 dollar deductible and 20 percent coinsurance amounts to a few dollars of drug. Injections are also given on a recurring schedule that no travel plan can match. The genuine travel case on this page is vitrectomy, MIGS and incisional glaucoma surgery, where operating time rather than a vial drives the bill. The domestic drug tier changes the arithmetic mainly for self-funded patients facing licensed-agent pricing at home.
How much does vitrectomy cost in China?
Vitrectomy at China's major retina centers costs about $2,500–4,500 per eye for international patients (standard ranges, researched July 2026), versus $10,000–15,000 US private-pay. Complex cases — combined cataract-vitrectomy, silicone-oil tamponade, re-operations — price toward or above the top of the range and are quoted per case after imaging.
Can I fly to China for a retinal detachment?
No — do not plan travel around acute retinal symptoms. Sudden flashes, a shower of new floaters, or a curtain across your vision need emergency assessment within days wherever you are. Medical travel to China makes sense for scheduled retina care: planned vitrectomy for stable conditions, anti-VEGF course reviews, or diabetic retinopathy management — always confirmed by a specialist first.
Is it practical to manage a chronic condition like glaucoma from abroad?
Only with a handover plan. Glaucoma is lifelong: a laser or surgery in China lowers pressure, but someone at home must keep measuring it. Reputable Chinese centers provide English reports with your pressure history, visual fields, OCT scans and the exact procedure performed, so your home ophthalmologist can continue monitoring. If you have no home eye doctor willing to follow up, treat that as a reason to pause, not a detail to solve later.
Which hospitals in China treat glaucoma and retinal disease?
The main academic centers all run dedicated glaucoma and vitreoretinal subspecialty departments: Zhongshan Ophthalmic Center (Guangzhou), Beijing Tongren, the Eye & ENT Hospital of Fudan University (Shanghai), Tianjin Eye Hospital and Wenzhou Medical University Eye Hospital, plus private networks such as Aier and He Eye Specialist Hospital with international patient services. Complex retina surgery in particular belongs at a high-volume vitreoretinal unit.
Why is glaucoma and retina care so much cheaper in China?
Cost structure and volume, not a different standard of care. Chinese academic eye centers use the same lasers, vitrectomy platforms and anti-VEGF drug classes as Western hospitals while operating at some of the world's highest patient volumes with far lower facility costs. Domestic drug and device alternatives (conbercept, domestic stents) add a lower-priced tier that simply doesn't exist in most Western systems.
Can MIGS be combined with cataract surgery in one trip?
Frequently, yes — a stent placed during cataract surgery is one of the most common MIGS patterns, and it fits the same 6–8 day both-eyes cataract itinerary. Whether your angle anatomy and disease stage suit it is decided by the surgeon after imaging. See our cataract cost guide for that trip's pricing and timeline.
Does China treat angle-closure glaucoma differently?
The ladder is different; the standard is not. Angle-closure is the form China sees most — an estimated 28.2 million angle-closure suspects and 9.1 million people with primary angle closure live there — so its academic eye centers carry unusually deep experience with it. Treatment starts with laser peripheral iridotomy or, following the EAGLE trial (Lancet, 2016), early clear-lens extraction, which gave better pressure control and fewer subsequent procedures than iridotomy at three years. If lens extraction is the plan, the figure you should be comparing is a cataract-surgery price, not a glaucoma-surgery price. Which applies to your eyes is settled by gonioscopy and imaging with the treating specialist, not by a price list.
My trabeculectomy failed — can I have a tube shunt in China?
It is a recognised route, and Chinese academic eye centers implant the same devices — Ahmed, Baerveldt and PAUL — but it is quoted per case rather than from a standard range, because the device tier and the condition of the eye set the price. Domestic published pricing for a drainage implant runs about ¥28,000–38,000 all-in, roughly $3,900–5,300 per eye at August 2026 rates, against US private-pay references of about $4,000–8,000. Two honest points. The saving on this rung is the smallest on this page, because an imported valve costs much the same everywhere. And a re-operated eye needs the densest follow-up schedule of any procedure here, which is the hardest thing to arrange from abroad — confirm who is doing your post-operative reviews at home before you book anything.
Will I need cataract surgery after a vitrectomy?
If you still have your own lens and you are over 50, expect it. Removing the vitreous accelerates lens opacification — nuclear-sclerosis progression runs around sixfold faster in eyes over 50 than in younger eyes, most of the change happens inside about two years, and roughly 60% of patients have cataract surgery in that window. For a traveller this is the most predictable cost on the page, because it is a second operation and usually a second trip. It is worth asking your surgeon directly whether combined phaco-vitrectomy suits your eye: doing both in one visit is often the difference between one itinerary and two, and it changes the quote given at the in-person work-up. Whether combining is appropriate depends on your retina and your lens and is decided by the operating surgeon after imaging.
If my retinal detachment re-detaches, who pays for the second operation?
Ask before you travel, and get the answer in writing — the price you are quoted is a single-operation price. Modern single-operation reattachment success is roughly 90–95%, so a minority of eyes need a further procedure, and a re-operation abroad means a second international trip on top of the surgical fee unless it happens while you are still in-country. Reputable partner hospitals will state what a re-operation is priced at and what, if anything, is covered; an unwillingness to answer is itself informative. This is also the strongest argument for having a named ophthalmologist at home before you book, since a late re-detachment is diagnosed by whoever is examining you then.